Join us as we discuss BlueRock Therapeutic's new cell therapy DA01 currently in phase I clinical trials. Dr. Fasano and Dr. Enayetallah break down how this therapy has the potential to revolutionize the Parkinson's treatment landscape by providing tonic dopamine release and addressing underlying neuron degeneration.
Learn more about the clinical trial here.
Access the transcript here.
Join us this episode as Dr. Ziv Gan-Or breaks down lysosomal dysfunction and REM sleep behaviour disorders and how this complicates our current understanding of Parkinson's Disease.
Transcript available here
In this episode, we discuss the neuroprotective genes Parkin and PINK1, their implication in the development of early-onset Parkinson's Disease, and their possible therapeutic potential.
Transcript can be found here
Questions for Dr. Trempe? Contact him at this address: jeanfrancois.trempe@mcgill.ca
In this episode we are joined by Dr. Edward Fon to discuss the genetics behind familial Parkinson's disease, how our understanding of genes can work to create treatments and understanding of all forms of Parkinson's, what PD research will look like in the future, and how COVID-19 is affecting patients, researchers, and possible susceptibility that could accompany having PD.
Find a transcript of the Podcast here.
In this episode we discuss the effects of chronic Parkinson's treatment, deep brain stimulation, and other treatment options that are recommended to manage side effects of continuous treatment.
Transcript can be found here.
In this podcast we discuss onset factors of Parkinson's Disease (PD), the future medicine and treatment that could occur with the use of patient-derived induced pluripotent stem cell, and how COVID-19 is impacting patients and researchers.
To read the transcript of the podcast, please visit our website here.